Luka Dončić (38 pts, 13 reb, 10 ast, 2 stl) led the Lakers over the Nuggets 115-107 in the nightcap of our NBC and Peacock ...
Daily Voice on MSN
FDA warns consumers after nationwide dietary supplement recall
A dietary supplement marketed for joint and body aches has been pulled from shelves nationwide after federal regulators determined it contains a hidden prescription drug. Anthony Trinh, 123Herbals LLC ...
Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years. Kleck, 32, of Santa Cruz, was diagnosed with the rarer Type 1 diabetes at age ...
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs. By Rebecca Robbins The Food and Drug Administration ...
Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...
Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Gavin Newsom announced Thursday, Oct. 16. Long-acting insulin pens will be ...
Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Gavin Newsom announced today. Long-acting insulin pens will be available ...
California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...
As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood sugar control in people with diabetes. The approval is for a 3 milliliter (mL) single-patient-use prefilled ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Sanofi is joining its fellow drugmakers in trying to put new restrictions on savings sent to hospitals in a federal drug discount program. A spokesperson for Sanofi confirmed plans to implement a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results